Michelle Kameda-Smith to Cell Line, Tumor
This is a "connection" page, showing publications Michelle Kameda-Smith has written about Cell Line, Tumor.
Connection Strength
0.084
-
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma. J Neurooncol. 2023 Jul; 163(3):635-645.
Score: 0.033
-
Wnt activation as a therapeutic strategy in medulloblastoma. Nat Commun. 2020 08 28; 11(1):4323.
Score: 0.027
-
BMI1 is a therapeutic target in recurrent medulloblastoma. Oncogene. 2019 03; 38(10):1702-1716.
Score: 0.024